Company Monitoring Page for Alexion

latest headlines for company on cafepharma

AstraZeneca's planned takeover of Alexion clears last regulatory review, deal to close next week
Endpoints
Wed, 07/14/21 - 10:17 am
Tags:
AstraZeneca, Alexion, M&A
AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance
PM Live
Tue, 07/6/21 - 10:59 am
Tags:
AstraZeneca, Alexion, M&A, Europe
Key third-quarter readouts for big pharma
EP Vantage
Tue, 06/29/21 - 10:59 am
Tags:
clinical trials, Pfizer, Roche, idanacogene elaparvovec, Alexion, AstraZeneca, Ultomiris, AbbVie, Rinvoq, Novartis, sabatolimab
Alexion, AstraZeneca executives switch roles amid $39B buyout
BioPharma Dive
Sun, 06/6/21 - 10:33 pm
Tags:
AstraZeneca, Alexion, M&A
Apellis set to take on Alexion as FDA clears PNH drug Empaveli
Pharmaforum
Mon, 05/17/21 - 10:39 am
Tags:
Apellis Pharmaceuticals, Alexion, Empaveli, FDA, PNH
Alexion Investors Approve Acquisition By AstraZeneca
Yahoo/SmarterAnalyst
Wed, 05/12/21 - 10:46 am
Tags:
AstraZeneca, Alexion, M&A
AZ posts solid Q1 results as Alexion merger looms
Pharmforum
Fri, 04/30/21 - 10:27 am
Tags:
AstraZeneca, M&A, Alexion, vaccines, earnings
Surprise: AstraZeneca's $39B Alexion buy clears a newly vigilant FTC without a hitch
Fierce Pharma
Sun, 04/18/21 - 12:04 am
Tags:
AstraZeneca, Alexion, M&A, FTC
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
Tags:
M&A, Alexion, Amgen, AstraZeneca, Biogen, Five Prime Therapeutics, Gilead Sciences, GW Pharma, Horizon Therapeutics, Immunomedics, Jazz Pharmaceutical, Kymab, Merck, Pandion, Sanofi, Viela Bio
BridgeBio spins gold out of an Alexion castoff, scoring an FDA approval in rare metabolism disorder
Endpoints
Mon, 03/1/21 - 10:36 am
Tags:
BridgeBio, fosdenopterin, Nulibry, ALXN1101, molybdenum cofactor deficiency type A, FDA, Alexion
Apellis takes the complement fight to Astrazeneca
EP Vantage
Fri, 01/22/21 - 10:30 am
Tags:
Apellis, Alexion, AstraZeneca, PNH
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
Tue, 01/19/21 - 10:30 am
Tags:
M&A, AstraZeneca, Alexion, Bristol-Myers Squibb, MyoKardia, Gilead Sciences, Forty Seven, Merck, VelosBio, Nestle, Aimmune, Immunomedics, JNJ, Momenta Pharmaceuticals, Sanofi, Principia Biopharma, Bayer, Asklepios BioPharmaeutical
Newly acquired Alexion pays $100M for Rhythm's speedy review voucher
Fierce Biotech
Wed, 01/6/21 - 10:54 am
Tags:
AstraZeneca, Alexion, Rhythm, priority review vouchers
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
Wed, 01/6/21 - 10:41 am
Tags:
M&A, AstraZeneca, Alexion, Bristol-Myers Squibb, MyoKardia, Bayer, Asklepios, Merck, VelosBio, Gilead Sciences, Forty Seven, Immunomedics, JNJ, Momenta
The top 5 pharma M&A deals of 2020
Pharmaforum
Mon, 12/21/20 - 11:07 am
Tags:
M&A, AstraZeneca, Alexion, Gilead Sciences, Immunomedics, Forty Seven, JNJ, Momenta, Sanofi, Principia Biopharma
[video+transcript]Is AstraZeneca Paying Too Much for Alexion?
Motley Fool
Mon, 12/21/20 - 11:00 am
Tags:
M&A, AstraZeneca, Alexion
Pharmacquired: What a surprise deal does for AstraZeneca and Alexion
BioPharma Dive
Wed, 12/16/20 - 11:31 am
Tags:
AstraZeneca, Alexion, M&A, Rare Diseases
AstraZeneca to buy Alexion for $39B
BioPharma Dive
Sat, 12/12/20 - 02:30 pm
Tags:
AstraZeneca, Alexion, M&A, Rare Diseases
Alexion dumps ex-Achillion C3G program after seeing phase 2 data
Fierce Biotech
Thu, 07/30/20 - 11:01 am
Tags:
Alexion, Achillion, M&A, clinical trials
Biopharma takeovers show quantity, if not quality
EP Vantage
Mon, 07/13/20 - 11:13 am
Tags:
COVID-19, pandemic, M&A, Novo Nordisk, Corvidia, Gilead Sciences, Pionyr, Alexion, Portola Pharmaceuticals, Menarini, Stemline Therapeutics, Shionogi, Tetra Therapeutics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.